Alpine Immune Sciences Ownership | Who Owns Alpine Immune Sciences?


OverviewForecastRevenueFinancialsChartTranscripts

Alpine Immune Sciences Ownership Summary


Alpine Immune Sciences is owned by 100.87% institutional investors. Capula management is the largest institutional shareholder, holding 0% of ALPN shares. NT R2000 Growth Index Fund - NL is the top mutual fund, with 0.07% of its assets in Alpine Immune Sciences shares.

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Capula management---
Highpoint advisor group---
First trust advisors lp---
Woodline partners lp---
Scientech research---
Price t rowe associates inc /md/---
Darwin global management---
Geode capital management---
Voya investment management---
Algert global---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Capula management---
Highpoint advisor group---
First trust advisors lp---
Woodline partners lp---
Scientech research---
Price t rowe associates inc /md/---
Darwin global management---
Geode capital management---
Voya investment management---
Algert global---

Top Buyers

HolderShares% AssetsChange
Rothschild investment---5.00
Nelson, van denburg & campbell wealth management group---6.00
Principal securities---6.00
Riggs asset managment---16.00
Farther finance advisors---20.00

Top Sellers

HolderShares% AssetsChange
Decheng capital---8.32M
Avoro capital advisors---5.78M
Blackrock---3.58M
Frazier life sciences management---3.13M
Price t rowe associates inc /md/---3.08M

Sold Out

HolderChange
Rothschild investment-5.00
Nelson, van denburg & campbell wealth management group-6.00
Principal securities-6.00
Riggs asset managment-16.00
Farther finance advisors-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202419040.74%64,590,3709.60%1000.73%12910.26%42320.00%
Dec 31, 202313551.69%58,933,18028.33%1171.35%117129.41%10-52.38%
Sep 30, 20238915.58%45,924,84124.14%931.57%51-3.77%2175.00%
Jun 30, 20237730.51%36,995,1076.71%761.45%5370.97%12-7.69%
Mar 31, 202359-7.81%34,668,7531.33%721.31%31-24.39%1344.44%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
NT R2000 Growth Index Fund - NL50.66K0.07%-
NT R2000 Value Index Fund - NL43.88K0.06%-
The Vanguard Russell 2000 Growth Index32.45K0.05%-137.00
Acuitas US Microcap Strategy31.90K0.05%-
Vanguard Instl Ttl Stck Mkt Idx Tr30.72K0.04%7.87K
ProFunds Biotechnology UltraSector Inv22.42K0.03%13.89K
SSgA U.S. Extended Market Index Class I19.00K0.03%8.30K
TD Health Sciences - I16.60K0.02%16.60K
Blackstone Alternative Multi-Strategy I10.70K0.02%6.90K
Pictet TR - Div Alpha J EUR10.17K0.01%10.17K

Insider Transactions Trends


DateBuySell
2024 Q2-1
2024 Q1-3
2023 Q4229
2023 Q2--
2023 Q1--

ALPN Ownership FAQ


Who owns the most shares of Alpine Immune Sciences?

Alpine Immune Sciences’s largest shareholders are Capula management (0 shares, 0%), Highpoint advisor group (0 shares, 0%), and First trust advisors lp (0 shares, 0%). Together, they hold 0% of Alpine Immune Sciences’s total shares outstanding.

Does Blackrock own Alpine Immune Sciences?

BlackRock is not among the top 10 institutional shareholders of Alpine Immune Sciences.

Who is Alpine Immune Sciences’s biggest shareholder by percentage of total assets invested?

Capula management is Alpine Immune Sciences’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Alpine Immune Sciences shares, valued at 0$.

Who is the top mutual fund holder of Alpine Immune Sciences shares?

NT R2000 Growth Index Fund - NL is the top mutual fund holder of Alpine Immune Sciences shares, with 0.07% of its total shares outstanding invested in 50.66K Alpine Immune Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools